Vimal Mehta, CEO and President, 10% Owner at BioXcel Therapeutics, Inc. (BTAI), sold 2,134 shares at $1.28 ($3K) on 2024-06-17, disclosed to the SEC on 2024-06-18.
Scheduled sale ($3k) by CEO and President, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |
| BTAI | SELL | 2023-06-16 | $2.5M | — | Filing → |